Helix BioPharma (TSE:HBP) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Helix BioPharma Corp. has appointed James B. Murphy as its new Chief Financial Officer, bringing his extensive experience in finance and operations management to the company. Murphy, a seasoned consultant in the life sciences industry, is expected to drive strategic growth and support Helix’s focus on advancing its CEACAM6 platform in oncology.
For further insights into TSE:HBP stock, check out TipRanks’ Stock Analysis page.
